Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression of biologically active human factor VIII using a baculovirus vector

E Webb1, J Tkalcevic, S Edwards

  • 1Research and Development Division, CSL Limited, Parkville, Victoria, Australia.

Biochemical and Biophysical Research Communications
|January 29, 1993
PubMed
Summary

This study demonstrates that insect cells can produce active, glycosylated Factor VIII (a key blood clotting protein) using a baculovirus expression system. This offers a promising alternative for more efficient recombinant Factor VIII production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New criteria for efficient Raman and Brillouin amplification of laser beams in plasma.

Scientific reports·2020
Same author

Introduction of a care bundle effectively and sustainably reduces patient-reported surgical site infection in patients undergoing colorectal surgery.

The Journal of hospital infection·2020
Same author

Physical activity accrued as part of public transport use in England.

Journal of public health (Oxford, England)·2018
Same author

Two synchronous non small cell lung carcinomas with different morphologies in the same lobe.

Journal of surgical case reports·2014
Same author

Commentary on the ISSOP policy statement on the UNCRC and health.

Child: care, health and development·2014
Same author

Use of impedance ratios to assess hand swelling in lymphoedema.

Phlebology·2012

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • Factor VIII is crucial for blood coagulation but recombinant production in mammalian cells is inefficient.
  • Baculovirus expression systems offer potential for higher glycoprotein yields.
  • The biological activity of insect cell-derived Factor VIII, particularly concerning glycosylation, was uncertain.

Purpose of the Study:

  • To engineer a B domain-deleted Factor VIII cDNA for expression in Spodoptera frugiperda insect cells.
  • To assess the feasibility of using a baculovirus system for Factor VIII production.
  • To determine if insect cell-derived Factor VIII is secreted, biologically active, and properly glycosylated.

Main Methods:

  • Engineered a B domain-deleted Factor VIII cDNA construct with a native signal sequence.

Related Experiment Videos

  • Expressed the construct in Spodoptera frugiperda cells using a baculovirus vector.
  • Analyzed the culture medium for secreted Factor VIII and assessed its coagulation activity.
  • Investigated the presence and nature of N-linked oligosaccharide residues.

    • Main Results:

    • Successfully produced and secreted recombinant Factor VIII into the culture medium.
    • Demonstrated that the secreted Factor VIII possesses significant coagulation activity.
    • Confirmed the presence of N-linked oligosaccharide residues on the insect cell-derived protein.
    • The glycosylated Factor VIII was similar in size to mammalian cell-derived Factor VIII.

    Conclusions:

    • Baculovirus expression in Spodoptera frugiperda cells is a viable method for producing biologically active, glycosylated Factor VIII.
    • Insect cell-derived Factor VIII shows potential as an alternative to mammalian cell systems for recombinant production.
    • The N-linked glycosylation in insect cells supports the activity and secretion of Factor VIII.